Heterogeneous associations of antidiabetic medications with cancer prognosis: Evidence from 61 studies with over 1.1 million patients.
- DOI
- 10.1016/j.phrs.2026.108420
- Published
- 2026 Oct
- Container
- Pharmacological research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.108420,
title = {Heterogeneous associations of antidiabetic medications with cancer prognosis: Evidence from 61 studies with over 1.1 million patients.},
author = {Luo P and Ding Y and Huang W and Ma W and Lan X and Zhang J and Yang X and Lin A},
year = {2026},
journal = {Pharmacological research},
doi = {10.1016/j.phrs.2026.108420},
url = {https://doi.org/10.1016/j.phrs.2026.108420}
}RIS
TY - JOUR TI - Heterogeneous associations of antidiabetic medications with cancer prognosis: Evidence from 61 studies with over 1.1 million patients. AU - Luo P AU - Ding Y AU - Huang W AU - Ma W AU - Lan X AU - Zhang J AU - Yang X AU - Lin A PY - 2026 JO - Pharmacological research DO - 10.1016/j.phrs.2026.108420 UR - https://doi.org/10.1016/j.phrs.2026.108420 ER -
APA
P, L., Y, D., W, H., W, M., X, L., J, Z., X, Y., & A, L. (2026). Heterogeneous associations of antidiabetic medications with cancer prognosis: Evidence from 61 studies with over 1.1 million patients.. Pharmacological research. https://doi.org/10.1016/j.phrs.2026.108420
Source records
- pubmed · retrieved 2026-09-25T08:47:28.248Z